Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000268 · ClinicalTrials.gov registry record · NA
Cocaine Abuse and Attention Deficit Disorder - 3
A NA study of Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT00000268: Completed NA study of Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000268 is a NA study of Cocaine-Related Disorders that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 32 participants, below the 63-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000268, a NA study of Cocaine-Related Disorders, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
Conditions Studied
Interventions
- DRUG Bupropion
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 1995-05 |
| Est. Completion | 1998-11 |
| Phase | NA |
What the finished NCT00000268 record still lists
NCT00000268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 63-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Bupropion is the first listed.
NCT00000268 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00000268 about?
NCT00000268 is a clinical study titled "Cocaine Abuse and Attention Deficit Disorder - 3". The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
What is the current status of trial NCT00000268?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 1995-05. Estimated completion is 1998-11.
What conditions does trial NCT00000268 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders.
What interventions are being tested in trial NCT00000268?
The interventions under investigation include: Bupropion (DRUG).
Who is sponsoring clinical trial NCT00000268?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000268 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00000268's enrollment target sits among peer trials
32 9th of 15 higher than 7 of 15 other Cocaine-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
-
Modeling Impaired Judgement in Cocaine Abusers - 6
COMPLETED · Phase 4
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
COMPLETED · Phase 2
-
Quetiapine for Cocaine Use and Cravings
COMPLETED · Phase 4
-
Dose Response Trial of Pergolide for Cocaine Dependence - 1
COMPLETED · Phase 3
-
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia